RadMD Expands Its Imaging Expertise Services With New European Office

DOYLESTOWN, PA--(Marketwire - May 23, 2012) - RadMD, LLC announces the opening of its European office to expand services to EU pharma, biotech, and medical device companies.

The new location will provide:

• A base for EU operations of consulting, training, and expert resourcing services centered on the use of imaging in clinical trials.
• An accessible location for RadMD’s expanding EU pool of expert independent radiologists and clinician reviewers.

The EU office is located in Lucca, Italy, approximately 20 minutes from Pisa airport. This is the third office for RadMD, with locations in Doylestown, PA and New York City.

Reader availability can be a rate-limiting step to complete independent image reviews -- “blinded reads” -- in clinical trials. By adding an expanded EU reader pool, RadMD can complete blinded reads faster, reducing read time and cost while maintaining quality through our proprietary Reader Performance Management (RPM™) tool. Global regulatory authorities emphasize the need for transparent and standardized training in clinical trials. As with RadMD’s existing reader pool, the new EU readers will also be certified through the company’s training program, BRITI™ (The Blinded Reader & Investigator Training Institute). In addition, by providing blinded reading locations in both the US and EU, RadMD can leverage readers to perform rapid reviews for any trial requiring rapid read turnaround time.

“Recognizing the importance of the expanding EU drug and device markets, we are very enthusiastic about the new location and value this will bring to new and existing clients. Our unique clinical, regulatory, and development expertise provides clients with both local EU experience as well as a global perspective on imaging in clinical trials,” according to Kohkan Shamsi, MD, PhD, co-founder and Principal.

About RadMD

RadMD, Inc. (www.rad-md.net) provides a suite of expertise-based services focused on imaging in clinical trials. These include clinico-regulatory strategy development; site reader and trial personnel training; and independent reader sourcing and performance management for the pharmaceutical, biotech, and medical device industries. Training and CME education is performed through RadMD’s educational branch, BRITI™.